About this document

Bedaquiline for Multi-Drug Resistant TB by Tristania Magdalena Retno Wulan is a document available to read on EtoBox.

This systematic literature review evaluates the effectiveness and safety of bedaquiline-containing regimens for treating multi-drug resistant tuberculosis (MDR-TB). The review found that bedaquiline significantly improves sputum culture conversion rates, with a range of 74%-95.8%, but also noted serious side effects, particularly QT prolongation. It concludes that while bedaquiline is effective and safe, careful monitoring is essential to mitigate risks associated with its use.

Author

Tristania Magdalena Retno Wulan

Language

EN